Apotheca Biosciences, Inc. (CBDC) financial statements (2020 and earlier)

Company profile

Business Address 10901 ROOSEVELT BLVD.,
SAINT PETERSBURG, FL 33716
State of Incorp. NV
Fiscal Year End January 31
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

4/30/2019
TTM
1/31/2019
1/31/2018
1/31/2017
1/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 3 03
Cash and cash equivalents 3 03
Inventory, net of allowances, customer advances and progress billings 8   
Inventory 8   
Prepaid expense 6   
Deposits current assets 6   
Other undisclosed current assets 86   
Total current assets: 109 03
Noncurrent Assets
Property, plant and equipment 6   
Total noncurrent assets: 6   
TOTAL ASSETS: 115 03
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 1071851
Accounts payable 24   
Accrued liabilities 83   
Other undisclosed accounts payable and accrued liabilities  1851
Debt 19157  
Due to related parties 8472928
Total current liabilities: 1342223329
Noncurrent Liabilities
Other undisclosed liabilities 798   
Total liabilities: 9322223329
Stockholders' equity
Stockholders' equity attributable to parent, including: (817)(222)(33)(26)
Common stock 11850  
Additional paid in capital 1,504173827
Accumulated deficit (2,512)(290)(79)(61)
Other undisclosed stockholders' equity attributable to parent 74 88
Total stockholders' equity: (817)(222)(33)(26)
TOTAL LIABILITIES AND EQUITY: 115 03

Income statement (P&L) ($ in thousands)

4/30/2019
TTM
1/31/2019
1/31/2018
1/31/2017
1/31/2016
Gross profit:  (62)  
Operating expenses (2,276)(188)(15)(34)
Other undisclosed operating income  62  
Operating loss: (2,276)(188)(15)(34)
Nonoperating expense (236)(8)  
Loss before gain (loss) on sale of properties: (2,512)(196)(15)(34)
Other undisclosed net loss   (3)(5)
Net loss available to common stockholders, diluted: (2,512)(196)(18)(39)

Comprehensive Income ($ in thousands)

4/30/2019
TTM
1/31/2019
1/31/2018
1/31/2017
1/31/2016
Net loss: (2,512)(196)(18)(39)
Comprehensive loss, net of tax, attributable to parent: (2,512)(196)(18)(39)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: